A Study Of PF-06664178 In Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: PF-06664178|DRUG: PF-06664178
Sponsor: Pfizer